ONCOCYTE CORP COM NPV (POST REV SPLIT)ONCOCYTE CORP COM NPV (POST REV SPLIT)ONCOCYTE CORP COM NPV (POST REV SPLIT)

ONCOCYTE CORP COM NPV (POST REV SPLIT)

No trades
See on Supercharts

Price target

4.130.000.00%
The 2 analysts offering 1 year price forecasts for 0KCC have a max estimate of — and a min estimate of —.

Analyst rating

Based on 3 analysts giving stock ratings to 0KCC in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


0KCC EPS for the last quarter is −0.40 USD despite the estimation of −0.44 USD. In the next quarter EPS is expected to reach −0.43 USD. Track more of ONCOCYTE CORP COM NPV (POST REV SPLIT) financials and stay on top of what is up with the company.
In the next quarter ONCOCYTE CORP COM NPV (POST REV SPLIT) revenue is expected to reach ‪101.67 K‬ USD. Check out ONCOCYTE CORP COM NPV (POST REV SPLIT) revenue and earnings and make informed decisions.
According to analysts, 0KCC price target is 4.13 USD with a max estimate of 4.25 USD and a min estimate of 4.00 USD. Check if this forecast comes true in a year, meanwhile watch ONCOCYTE CORP COM NPV (POST REV SPLIT) stock price chart and keep track of the current situation with 0KCC news and stock market news.